...

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Hypomethylating Agents as Bridging Therapy before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myelomonocytic Leukemia?

【24h】

Hypomethylating Agents as Bridging Therapy before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myelomonocytic Leukemia?

机译：慢性粒细胞性白血病患者异基因造血干细胞移植前使用次甲基化剂作为桥接疗法？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2016年第1期|共2页
作者
Robin Marie; Fenaux Pierre;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Hypomethylating Agents as Bridging Therapy before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myelomonocytic Leukemia? [J] . Robin Marie, Fenaux Pierre Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第1期

机译：慢性粒细胞性白血病患者异基因造血干细胞移植前使用次甲基化剂作为桥接疗法？
2. DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia [J] . Christian Flotho, Sebastian Sommer, Michael Lübbert Seminars in cancer biology . 2018,第期

机译：DNA-低甲基化剂作为表观遗传疗法在同种异体造血干细胞移植术前后骨髓增生综合征和青少年骨髓细胞白血病中的同种异体造血干细胞移植
3. Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia [J] . Kongtim Piyanuch, Popat Uday, Jimenez Antonio, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第1期

机译：同种异体干细胞移植前用低甲基化剂治疗可改善慢性粒细胞单核细胞白血病患者的无进展生存率
4. HIGH DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH PRIMARY SYSTEMIC AMYLOIDOSIS (AL): AN ABMTR STUDY [C] . DH Vesole, W Perez, D Reece, International Symposium on Amyloidosis . 2005

机译：具有自体造血干细胞移植（HSCT）的高剂量治疗用于初级全身淀粉样蛋白症（AL）的患者：ABMTR研究
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression Free Survival for Patients with Chronic Myelomonocytic Leukemia [O] . Piyanuch Kongtim, Uday Popat, Antonio Jimenez, -1

机译：同种异体干细胞移植前用低甲基化剂治疗可改善慢性粒单核细胞白血病患者的无进展生存期
7. Hypomethylating Agents as Bridging Therapy before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myelomonocytic Leukemia? [O] . Robin Marie, Fenaux Pierre 2016

机译：低甲基化剂作为慢性粒细胞性白血病患者异基因造血干细胞移植前的桥梁疗法？

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号